Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hajime Sugiyama is active.

Publication


Featured researches published by Hajime Sugiyama.


Biochemical and Biophysical Research Communications | 2009

Insight into estrogenicity of phytoestrogens using in silico simulation.

Hajime Sugiyama; Takuya Kumamoto; Akiko Suganami; Waka Nakanishi; Yoshihiro Sowa; Masaki Takiguchi; Tsutomu Ishikawa; Yutaka Tamura

Phytoestrogens, including miroestrol and deoxymiroestrol, have the ability to act through competition with estrogen for binding to the estrogen receptor (ER). Here, we utilize manual ligand docking followed by molecular dynamics simulations and binding free energy calculations with the linear interaction energy method to predict the binding modes and the binding affinities of phytoestrogens on the ligand binding domain of ER (ERalpha-LBD). The calculations brought about the good correlation between the calculated binding free energy and the bioassays. Furthermore, consideration of Lennard-Jones and Coulomb interaction energies of miroestrol and deoxymiroestrol on ERalpha-LBD provided the information to develop the phytoestrogen derivatives as the preferred drug for ER positive breast cancer treatment.


Journal of Biological Rhythms | 2007

Multifactorial Regulation of Daily Rhythms in Expression of the Metabolically Responsive Gene Spot14 in the Mouse Liver

Akinori Ishihara; Eriko Matsumoto; Kazumasa Horikawa; Takashi Kudo; Eiko Sakao; Ayako Nemoto; Katsuro Iwase; Hajime Sugiyama; Yutaka Tamura; Shigenobu Shibata; Masaki Takiguchi

Spot14 is a putative transcriptional regulator for genes involved in fatty acid synthesis. The Spot14 gene is activated in response to lipogenic stimuli such as dietary carbohydrate and is also under circadian regulation. The authors investigated factors responsible for daily oscillation of Spot14 expression. If mice were kept under a 12-h light/12-h dark cycle with ad libitum feeding, Spot14 mRNA levels in the liver reached a peak at an early dark period when mice, as nocturnal animals, start feeding. Under fasting, while Spot14 mRNA levels were generally decreased, the rhythmicity was still maintained, suggesting contribution of both nutritional elements and circadian clock factors on robust rhythmicity of Spot14 expression. Effects of circadian clock factors were confirmed by the observations that the circadian rhythm of Spot14 expression was seen also under the constant darkness and that the rhythmicity was lost in Clock mutant mice. When mice were housed in short-photoperiod (6-h light/18-h dark) and long-photoperiod (18-h light/6-h dark) cycles, rhythms of Spot14 mRNA levels were phase advanced and phase delayed, respectively, being concordant with the notion that Spot14 expression is under the control of the light-entrainable oscillator. As for nutritional mediators, in the liver of db/db mice exhibiting hyperinsulinemia-accompanied hyperglycemia, Spot14 mRNA levels were constantly high without apparent rhythmicity, consistent with previous observations for strong activation of the Spot14 gene by glucose and insulin. Restricted feeding during the 4-h mid-light period caused a phase advance of the Spot14 expression rhythm. On the other hand, restricted feeding during the 4-h mid-dark period led to damping of the rhythmicity, apparently resulting from the separation of phases between effects of the light/dark cycle and feeding on Spot14 expression. Thus, the daily rhythm of Spot14 expression in the liver is under the control of the light-entrainable oscillator, food-entrainable oscillator, and food-derived nutrients, in a separate or cooperative manner.


Chemical Biology & Drug Design | 2011

Knowledge‐Based Identification of the ERK2/STAT3 Signal Pathway as a Therapeutic Target for Type 2 Diabetes and Drug Discovery

Takayoshi Kinoshita; Kentaro Doi; Hajime Sugiyama; Shuhei Kinoshita; Mutsuyo Wada; Shuji Naruto; Atsushi Tomonaga

Many existing agents for diabetes therapy are unable to restore or maintain normal glucose homeostasis or prevent the eventual emergence of hyperglycemia‐related complication. Therefore, agents based on novel mechanisms are sought to complement and extend the current therapeutic approaches. Based on the initial paper research, we focused on active STAT3 as an attractive pharmacological target for type 2 diabetes. The subsequent text mining with a unique query to identify suppressors but not activators of STAT3 revealed the ERK2/STAT3 pathway as a novel diabetes target. The description of ERK2 inhibitors as diabetes target had not been found in our text mining research at present. The mechanism‐based peptide inhibitor for ERK2 was identified using the knowledge of the KIM sequence, which has an important role in the recognition of cognate kinases, phosphatases, scaffold proteins, and substrates. The peptide inhibitor was confirmed to exert effects in vitro and in vivo. The peptide inhibitor conferred a significant decrease in HOMA‐IR levels on Day 28 compared with that in the vehicle group. Besides lowering the fasting blood glucose level, the peptide inhibitor also attenuated the blood glucose increment in the fed state, as compared with the vehicle group.


Bioorganic & Medicinal Chemistry Letters | 2016

Identification of allosteric ERK2 inhibitors through in silico biased screening and competitive binding assay.

Takayoshi Kinoshita; Hajime Sugiyama; Yurika Mori; Naruhide Takahashi; Atsushi Tomonaga

Extracellular signal-regulated kinase 2 (ERK2) is a drug target for type 2 diabetes mellitus. A peptide-type ERK2 inhibitor (PEP) was discovered in the previous study through the knowledge-based method and showed physiological effects on the db/db mice model of type 2 diabetes. Here, the crystal structure showed that PEP bound to the allosteric site without the interruption of the ATP competitive inhibitor binding to ERK2. An in silico biased-screening using the focused library rendered three compounds with inhibitory activity of IC50 <100 μM. Among them, two compounds revealed the concentration-dependent competition with PEP and could be lead compounds for antidiabetic medicine.


FEBS Journal | 2016

Human DP and EP2 prostanoid receptors take on distinct forms depending on the diverse binding of different ligands

Akiko Suganami; Hiromichi Fujino; Iori Okura; Naoki Yanagisawa; Hajime Sugiyama; John W. Regan; Yutaka Tamura; Toshihiko Murayama

Human D‐type prostanoid (DP) and E‐type prostanoid 2 (EP2) receptors are G protein‐coupled receptors and are regarded as the most closely related receptors among prostanoid receptors because they are generated by tandem duplication. The DP receptor‐cognate ligand, prostaglandin D2 (PGD2) has the ability to activate not only DP receptors but also EP2 receptors. Likewise, the EP2 receptor‐cognate ligand, prostaglandin E2 (PGE2) has the ability to activate DP receptors in addition to EP receptors in order to stimulate cAMP formation. However, since PGD2 and/or PGE2 activate DP and EP2 receptors to similar maximal levels, that is, their similar efficacies, differences between the ligands in each receptor have not yet been determined in detail except for their different affinities. Herein we demonstrated, using an in silico simulation to predict binding patterns among DP or EP2 receptors and PGD2, PGE2, or prostaglandin F2α as the reference prostanoid, that DP and EP2 receptors plausibly take on distinct forms depending on the diverse binding of different ligands. Since these ligands have the potential to make these receptors form distinct conformations with discrete signaling pathways, they are consequently regarded as endogenous biased ligands. Moreover, by using functional assays, the susceptibilities of the DP receptors to the noncognate ligands were approximately 10 times lower than those of EP2 receptors. Thus, EP2 receptors seem to be able to distinguish endogenous ligands better than DP receptors, thereby both receptors are plausibly gaining role‐sharing functions with respect to one another as the copies of duplicated gene.


Biochemical and Biophysical Research Communications | 2013

Prediction of the interaction between spermidine and the G-G mismatch containing acceptor stem in tRNAIle: Molecular modeling, density functional theory, and molecular dynamics study

Yoshihiro Hayashi; Hajime Sugiyama; Akiko Suganami; Kyohei Higashi; Keiko Kashiwagi; Kazuei Igarashi; Susumu Kawauchi; Yutaka Tamura

Polyamines, putrescine, spermidine (SPD), and spermine are closely linked to cell growth, and highly regulate the levels of transcription, translation and protein turnover. We propose that SPD stimulates the formation of Ile-tRNA(Ile) by inducing a selective structural change of the G-G mismatch containing acceptor stem in tRNA(Ile). Here, we provide insight into how SPD recognizes and stabilizes the G-G mismatch containing acceptor stem in tRNA(Ile) with molecular modeling (MM), density functional theory (DFT) calculations, and molecular dynamics (MD) simulations. The results of the MM and DFT calculations indicate that the negatively charged region of the G-G mismatch containing acceptor stem in tRNA(Ile) is preferentially recognized by positively charged SPD. In addition, MD simulations indicate that all of the positively charged amino groups of SPD under physiological conditions (N1(NH3(+)), N5(NH2(+)), and N10(NH3(+)) could form hydrogen bonds with tRNA(Ile) and trigger the SPD-induced stabilization and structural change of the G-G mismatch containing acceptor stem in tRNA(Ile). Thus, this approach should be useful for determining the preferential binding site and appropriate binding mode of polyamines on tRNA(Ile).


Protein and Peptide Letters | 2009

Screening of SMG7-Binding Peptides by Combination of Phage Display and Docking Simulation Analysis

Muhammed Zahed; Toshikazu Suzuki; Akiko Suganami; Hajime Sugiyama; Kazuo Harada; Masaki Takiguchi; Yutaka Tamura; Nobuo Suzuki

We screened SMG7-binding peptides with phage display and docking simulation analysis. Although a consensus motif was absent in the phage display-derived candidates, we succeeded to find a peptide CDDRPPKSC, which can bind specifically to SMG7. We conclude that docking simulation helps to find high-affinity peptides efficiently, even if the phage display-screened candidates lack a consensus region.


Archive | 2013

PROGRAM FOR DESIGNING COMPOUND, DEVICE FOR DESIGNING COMPOUND, AND METHOD FOR DESIGNING COMPOUND

Shunji Matsumoto; Atsushi Tomonaga; Nozomu Kamiya; Hajime Sugiyama


Nucleic acids symposium series (2004) | 2005

Computational evaluation of the specific interaction between cation and mismatch base pair

Hajime Sugiyama; Nobue Adachi; Susumu Kawauchi; Tetsuo Kozasa; Takuma Katayama; Hidetaka Torigoe; Akira Ono; Yutaka Tamura


Archive | 2005

Method and apparatus for generating biologically-active-substance candidate structure

Atsushi Tomonaga; Noriyuki Shiobara; Hajime Sugiyama

Collaboration


Dive into the Hajime Sugiyama's collaboration.

Researchain Logo
Decentralizing Knowledge